|
This activity is sponsored by the Dermatology Nurses' Association.
This activity is funded through an educational grant from Abbott.
|
 |
This free CNE activity is based on presentations given at the CNE satellite symposium titled Patient Profiles In Psoriatic Disease: A Case-Based Approach, which was held on February 3, 2007 in Arlington, Virginia. Persons who attended the symposium are NOT eligible to receive CNE credit for this online activity. Please note that the course is accredited only for nurses. All other participants receive a certificate of completion. The Dermatology Nurses' Association (DNA) is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA). The DNA must ensure balance, independence, objectivity, and scientific rigor in its educational activities. All faculty are required to disclose relationships with commercial grantors or products. Faculty are also required to identify trade names, investigational products, and unlabeled uses that are discussed in their presentations. Disclosure is included on this Web site so participants may formulate their own judgment regarding the presentations. © 2007 Emeritus Educational Sciences. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems without permission in writing from Emeritus Educational Sciences.
Learning Objectives Upon completion of this activity, participants should be able to
Accreditation and Designation Statement The Dermatology Nurses' Association (DNA) is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA). The DNA is also an approved provider of continuing education in nursing by the California Board of Registered Nursing, BRN CEP Provider No. 05708. This activity will provide 1.25 contact hours. Provision of contact hours refers only to continuing education activities and does not imply endorsement of any commercial product by ANCC-COA or DNA. Funding Statement This activity is funded through an educational grant from Abbott. Activity Purpose This activity explains PsA and discusses how early recognition of the disease can prompt treatment and improve long-term outcomes. Statement of Need Psoriasis has been diagnosed in almost 6 million Americans. Of those, 6-39% also experience PsA. Clinical studies demonstrate that joint damage occurs in many individuals with psoriasis well before the clinical manifestations of joint disease are present. Early recognition of the associated signs and symptoms of PsA could impact disease management. Faculty Disclosures The Dermatology Nurses' Association (DNA) is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA). The DNA must ensure balance, independence, objectivity, and scientific rigor in its educational activities. All faculty are required to disclose relationships with commercial grantors or products. Faculty are also required to identify trade names, investigational products, and unlabeled uses that are discussed in their presentations. Disclosure is included on this Web site so participants may formulate their own judgment regarding the presentations. Mary Wiatrowski, RN, DNC Mary Wiatrowski received her nursing degree from Trocaire College in Buffalo, New York. She serves as clinical coordinator for Texas Dermatology Associates' Specialty Psoriasis Clinic in Dallas, Texas and has treated psoriasis patients with Alan Menter, MD, for more than a decade. The clinic, one of the largest in the world, has a research department, infusion center, and a phototherapy department. Ms Wiatrowski presented at the American Academy of Dermatologists conventions in 2004, 2005, and 2006 regarding nursing aspects of therapy. She has also served as a guest speaker for the National Psoriasis Foundation and at psoriasis therapy meetings. Nicole Furfaro, MSN, ARNP Nicole Furfaro completed her bachelor of science in nursing at Washington State University and her master's degree as a Family Practice Nurse Practitioner at Seattle University. She is actively involved in direct patient care and research and provides community and professional education on rheumatic diseases and treatments. Ms Furfaro has worked with psoriatic arthritis and other rheumatic diseases for over 12 years. She is currently employed at Seattle Rheumatology Associates, working with Philip Mease, MD. Instructions to Participants Course participants must view the slide presentations and complete both a test and a course evaluation to receive continuing nursing education credit. No fees are charged to participate in the program or to receive the certificate. Full instructions are available on the user instructions page. Disclaimer The opinions expressed herein are those of the faculty and do not necessarily represent the views of the sponsors, commercial supporters, or publisher. Please review complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients. Medicine is a constantly changing science, and clearly established therapies are not always available for every condition. New research findings necessitate continual changes in drug and treatment therapies. Reasonable efforts have been made to provide up-to-date, accurate information that is within generally accepted medical standards at the time of publication. However, as medical science is ever evolving, and human error is always possible, the provider, commercial supporters, and publisher (or any other involved party) do not guarantee total accuracy or comprehensiveness of the information in this activity, and they are not responsible for omissions or errors or the results of using information provided in this course. Participants should confirm the accuracy of the information in this activity from other sources. In particular, all drug doses, indications, and contraindications should be confirmed in package inserts.Click here to view minimum system requirements.
|
